25 May 2013
Keywords: costs, drag, losses, lower, regeneron, new, york
Article | 19 May 2003
New York, USA-based biotechnology concern Regeneron has reported a net loss of $30.1 million, or $0.68 per share, for the first quarter ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 May 2003
24 May 2013
© 2013 thepharmaletter.com